Study of Hemostasis During the Atrial Fibrillation Ablation Procedure (EHPAFAVE)

  • STATUS
    Recruiting
  • participants needed
    15
  • sponsor
    University Hospital, Strasbourg, France
Send
Updated on 22 November 2021
See if I qualify
Online studies

Summary

Due to the high thrombotic risk during the atrial fibrillation procedure, new guidelines have been proposed to maintain direct oral anticoagulant therapy during the perioperative period. This resulted in a significant change in the activated clotting time (ACT) at the beginning of the procedure, making it difficult to assess the level of heparinization during the procedure. The main objective of this study was to evaluate the correlation between laboratory hemostatic parameters, ACT and the dose of unfractionated heparin received. The secondary objective of this study was to correlate these results with hemorrhagic or thrombotic complications.

Description


Details
Condition Hemostasis
Age 18years or above
Clinical Study IdentifierNCT05128110
SponsorUniversity Hospital, Strasbourg, France
Last Modified on22 November 2021

Eligibility

 Yes No Not Sure

Inclusion Criteria

Patients over 18 years-old
with an atrial fibrillation
Operated for an atrial fibrillation procedure in the University hospital of Strasbourg
Without interruption of the direct oral anticoagulant
For whom extended biological assessment has been made in routine practice

Exclusion Criteria

Patients who refused the use of their data for this study
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact label
Race
Ethnicity
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

Online studies

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.